Investor Meeting Full Year Results; year ended Mar 31, 2005

Takakazu Morita President and CEO	Summary of Year Ended March 2005; Progress of 2003-2005 Medium-term Management Plan; Returning Profit to Shareholders; and Corporate Governance (PDF: 63KB)
Ichiro Otokozawa Senior Corporate Officer Head of Corporate Development and Administration Division	Consolidated Financial Results for the Year ended March 2005 and Consolidated Financial Forecasts for the Year ending March 2006 (PDF: 603KB)
Toshiaki Nishihata, Ph.D. Senior Corporate Officer Head of Research and Development Division	Status of Clinical Development (PDF: 41KB)